Opportunity ID: 351265

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-TR-24-001
Funding Opportunity Title: Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.350 — National Center for Advancing Translational Sciences
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 01, 2023
Last Updated Date: Dec 01, 2023
Original Closing Date for Applications: Mar 15, 2024
Current Closing Date for Applications: Mar 15, 2024
Archive Date: Apr 20, 2024
Estimated Total Program Funding:
Award Ceiling: $306,872
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: NCATS seeks to facilitate rare diseases research by enabling efficient and effective movement toward clinical trials in multiple rare diseases. The purpose of this NOFO is to provide support for basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease, and in the process to identify and overcome challenges in adapting the oncology basket trial model to rare diseases. Projects proposed for this NOFO will require individuals with expertise in carrying out clinical trials in rare diseases. Applicants are expected to collaborate with clinical investigators at academic institutions. Projects involving clinical investigators who are part of the Rare Disease Clinical Research Network (RDCRN) and which focus on diseases under study in the RDCRN are strongly encouraged. See https://www.rarediseasesnetwork.org/ for additional information.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-24-001.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 351265 Full Announcement-RFA-TR-24-001 -> RFA-TR-24-001-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00283988 Dec 04, 2023 Mar 15, 2024 View

Package 1

Mandatory forms

351265 RR_SF424_5_0-5.0.pdf

351265 PHS398_CoverPageSupplement_5_0-5.0.pdf

351265 RR_OtherProjectInfo_1_4-1.4.pdf

351265 PerformanceSite_4_0-4.0.pdf

351265 RR_KeyPersonExpanded_4_0-4.0.pdf

351265 RR_Budget_3_0-3.0.pdf

351265 PHS398_ResearchPlan_5_0-5.0.pdf

351265 SBIR_STTR_Information_3_0-3.0.pdf

351265 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

351265 RR_SubawardBudget30_3_0-3.0.pdf

351265 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T16:02:22-05:00

Share This Post, Choose Your Platform!

About the Author: